Nav: Home

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018

OAKLAND, Calif. May 16, 2018 -- Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types of blood clots than those who had abnormal heart rhythms for less time, according to a new Kaiser Permanente study.

Continuous heart monitoring may help physicians identify patients at higher risk and tailor treatments, according to the study published today in JAMA Cardiology.

"In our study, in people with the greatest burden of intermittently recurring atrial fibrillation those with the greatest burden defined as more than 11 percent of the time -- were the most likely to experience subsequent strokes or arterial blood clots, even after we controlled for all other important risk factors," said lead author Alan S. Go, MD, director of the Comprehensive Clinical Research Unit within the Kaiser Permanente Division of Research.

Both types of atrial fibrillation -- intermittently recurring and that which occurs 100 percent of the time -- can produce irregular and fast heartbeats, or arrhythmias. They affect millions of adults in the United States, and are linked to a higher risk of ischemic strokes and other types of blood clots. Currently, patients with any amount of atrial fibrillation are treated the same as those with chronic atrial fibrillation when it comes to stroke prevention, but whether these groups have an equal risk of strokes and blood clots has been controversial, explained Dr. Go.

The Kaiser Permanente Real-World Heart Monitoring Strategy Evaluation, Treatment Patterns, and Health Metrics in Atrial Fibrillation (known as KP-RHYTHM) study used a non-invasive, continuous electrocardiographic device to gather data on the amount of time people spent in the arrhythmias. Approved by the Food and Drug Administration, the monitoring device is a lightweight patch that adheres to the upper left chest, recording and storing beat-to-beat information for up to two weeks.

The study analyzed heart rhythm data for 1, 965 adult members of Kaiser Permanente living in California with confirmed intermittently recurring atrial fibrillation and is among the largest to employ continuous, non-invasive heart monitoring. Participants wore the monitoring device continuously for up to 14 days between October 2011 and October 2016 and were not taking anti-blood clotting medications during that time.

Study participants were followed through November 2016 to identify those hospitalized for ischemic stroke or arterial blood clots (thromboembolism) while not taking anti-blood-clotting (anti-coagulation) medications such as warfarin or direct oral anticoagulants.

"This study has the potential to have a major impact on heart care," said senior author Matthew D. Solomon, MD, PhD, a cardiologist at Kaiser Permanente in Oakland, California, and adjunct researcher at the Division of Research. "Using new continuous heart-monitoring technology, physicians can identify patients with intermittently recurring atrial fibrillation at greater risk and engage in better-informed shared decision-making around stroke prevention strategies."
-end-
This study was supported by a research grant from iRhythm Technologies, Inc.

In addition to Drs. Go and Solomon, co-authors were: Kristi Reynolds, PhD, MPH, and Teresa N. Harrison, SM, Department of Research and Evaluation, Kaiser Permanente Southern California; Jingrong Yang, MA, and Sue Hee Sung, MPH, Division of Research, Kaiser Permanente Northern California; Nigel Gupta, MD, Kaiser Permanente Los Angeles Medical Center; Judy Lenane, RN, MHA, iRhythm Technologies; and Taylor I. Liu, MD, PhD, Kaiser Permanente Santa Clara Medical Center.

About the Kaiser Permanente Division of Research

The Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. It seeks to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR's 550-plus staff is working on more than 350 epidemiological and health services research projects. For more information, visit divisionofresearch.kaiserpermanente.org or follow us @KPDOR.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 12 million members in eight states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to share.kaiserpermanente.org.

Kaiser Permanente

Related Atrial Fibrillation Articles:

Sleep apnea may increase atrial fibrillation risk
Obstructive sleep apnea (OSA) may increase the risk of developing atrial fibrillation (AF), according to new research presented at the ATS 2017 International Conference.
New study identifies biomarker that may indicate risk of atrial fibrillation
Researchers have identified a microRNA biomarker that demonstrates a strong association with the incidence of atrial fibrillation, the most common abnormal heart rhythm.
More women with atrial fibrillation die after ER discharge than men
A new study from the University of Alberta adds to the growing evidence that women with cardiovascular disease may receive different health care from men -- and experience worse outcomes.
Big women have nearly threefold greater risk of atrial fibrillation
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017.
Most atrial fibrillation patients don't get preventive drug before stroke
More than 80 percent of stroke patients with a history of atrial fibrillation either received not enough or no anticoagulation therapy prior to having a stroke, despite the drugs' proven record of reducing stroke risk, according to a Duke Clinical Research Institute study.
More than half of atrial fibrillation patients become asymptomatic after catheter ablation
More than half of patients with atrial fibrillation become asymptomatic after catheter ablation, reports the largest study of the procedure published today in European Heart Journal.
Medication adherence a problem in atrial fibrillation patients
Anticoagulant therapy is important for stroke prevention in people with atrial fibrillation, but a new study shows many people don't stick with it.
Atrial fibrillation patients are at increased risk of dementia, regardless of anticoagulation use
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
iPhone camera application may detect atrial fibrillation
A smartphone application made it possible to use the iPhone camera to detect atrial fibrillation via facial signals and without physical contact, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2016.
Study reports progress in preventing bleeding in atrial fibrillation
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.

Related Atrial Fibrillation Reading:

Beat Your A-Fib: The Essential Guide to Finding Your Cure: Written in everyday language for patients with Atrial Fibrillation
by Steve S Ryan PhD (Author), Patti J Ryan (Contributor)

Beat Your A-Fib: The Essential Guide to Finding Your Cure by Steve S. Ryan, PhD
Atrial Fibrillation (A-Fib) is the most common cardiac arrhythmia (abnormal heart rhythm) seen by physicians. Many patients suffering from Atrial Fibrillation have three strikes against them:
1. Their "quality of life" has deteriorated; they are scared or frightened.
2. Many experience side effects from the common drug therapies or simply do not want to live on medication; a cure for their A-Fib hasn't been discussed.
3. Patient information is often out-of-date, incomplete or biased... View Details


Atrial Fibrillation: Remineralize Your Heart

Atrial Fibrillation, an electrical disruption of the rhythm of the heart, is occurring in epidemic proportions. Medicine says there is no cure and only offers drugs and surgery for the symptoms. Because of my own heart palpitations, I searched for an effective treatment for many years. That treatment I found is based on the right kind of magnesium – one that doesn’t give you a laxative effect – well-absorbed multiple minerals and proper hydration with water and sea salt or Himalayan salt. Giving your heart the necessary minerals overcomes the electrical disruption and balances your... View Details


Conquer Your A-Fib: How To Beat Atrial Fibrillation
by Lisa M. White (Author)

Conquer your a-fib is a comprehensive guidebook for this very common arrhythmia. Containing a wealth of information and strategies for overcoming a-fib it covers: An introduction to a-fib, what it is and how it can be treated. Several causes of atrial fibrillation that you may not be aware of. Dietary and chemical triggers for a-fib Nutritional deficiencies as a potential trigger for episodes Modifiable risk factors for a-fib which can reduce and even cure your arrhythmia. Real life cases of people who have beaten a-fib. View Details


Lone Atrial Fibrillation Towards a Cure
by Hans R. Larsen (Author), Dr. Patrick Chambers MD (Contributor), Philippe Coumel MD FESC (Contributor)

Atrial fibrillation (AF) has been called the arrhythmia of the millennium. Millions of people suffer from lone atrial fibrillation (AF without underlying heart disease), and many don't even know they have it. There is no universally effective pharmacological treatment for lone atrial fibrillation (LAF) and relevant surgical procedures are expensive and not always successful.
I experienced my first LAF episode in 1989 and fairly early on in my afib "career" I realized that if anyone was going to help me it would have to be myself. So I embarked on an intensive study to find out... View Details


Atrial Fibrillation: How to Use Diet to Manage Atrial Fibrillations, Remineralize Your Heart, and Control Your Heart Rhythm
by Applied Knowledge

How to Use Natural Alternative Treatments to Beat Atrial Fibrillations, Remineralize Your Heart, and Manage Arrhythmias

Atrial Fibrillations or AFib occurs when arrhythmias, an arrhythmia is an instance where the heart beats too slow, too fast, or in an irregular manner, send rapid and disorganized electrical signals to the heart causing the upper two chambers of the heart, the left and right atria, to fibrillate (contract irregularly or too fast).

When you experience an aFib arrhythmia, blood pools in the upper two chambers of the heart, which hinders... View Details


Atrial Fibrillation: What You Need to Know: A Beginner's Guide for Patients and Caregivers (Consumer Health Guides Book 1)
by Eternal Spiral Books, http://EternalSpiralBooks.com

++The Fifth Edition, published September 8, 2014, is now available, with updates on the latest information on atrial fibrillation, including the latest news on dabigatran, (Pradaxa), and rivaroxaban, (Xarelto), two of the blood thinning medications (anticoagulants) often prescribed for patients with atrial fibrillation, plus news on the drug digoxin, and the effectiveness of catheter ablation for AFib.

Atrial Fibrillation is a particular type of irregular heart beat which can have dangerous consequences to your health if left untreated. People with atrial fibrillation, commonly... View Details


Atrial Fibrillation: A Multidisciplinary Approach to Improving Patient Outcomes (Cardiovascular Team Approach)
by N. A. Mark Estes III (Author), N. A. Mark Estes III (Editor), Albert L. Waldo (Editor), Joseph Alpert (Editor), Lynne T. Braun (Editor), Gerald Fletcher (Editor), Barbara Fletcher (Editor)

Atrial Fibrillation: A Multidisciplinary Approach to Improving Patient Outcomes, provides a current and comprehensive update on path physiology, epidemiology, management strategies of rate control, pharmacologic and nonpharmacologic approaches to rhythm control, risk stratification for stroke and bleeding, anticoagulant therapy, and left atrial occlusion devices. The contributions by experienced internists, cardiologists, electrophysiologists, surgeons, anesthesiologists, pharmacists, internists, nurse practitioners, and nurse educators provide a unique perspective. Case studies of... View Details


In a Heartbeat: The Ups and Downs of Life with Atrial Fib
by Rosalie Ungar (Author)

Halfway through her thirty-five-year bout with Atrial Fibrillation, Rosalie Ungar, at sixty-two, has a heart attack while giving a presentation on heart-healthy foods. So starts the battle to take control of her Atrial Fib and newer heart issues.

Told from the perspective of the patient, In A Heartbeat traverses the ups and downs of living and thriving with an irregular heart rhythm. Determined to question, challenge and negotiate doctors’ orders, Rosalie navigates changes in technology, pharmacology and physicians’ recommendations with a sharp wit and a tenacity for... View Details


A Life on Hold: Crossing Paths with Atrial Fibrillation
by Kevin J Kauffman (Author)

You're going about your daily routine when you suddenly feel an odd squirming in your chest. You quickly realize that it is your heart, flopping around like a fish out of water. What do you do? You probably panic! Maybe you also experience dizziness, nausea, or shortness of breath, or maybe you have no other symptoms at all. But it's still very scary because... it's your heart!

This is how chronic atrial fibrillation starts for many of us, and those who develop it often have little to no prior medical history to speak of. Once the demon a-fib has set in, though, we soon find our... View Details


Atrial Fibrillation : My Heart, the Doctors, and Me
by E. A. Butler (Author)

An Investigative Report by an Inquisitive Patient

The author felt compelled to write this story after discovering he had paroxysmal atrial fibrillation. He had little previous experience with personal illnesses. Now he found himself dealing with production line medicine. This experience fostered skepticism, doubts, apprehensions and grave concerns. He discovered he was afflicted with one of the most elusive and complex cardiovascular problems that involves the electrical impulse of the heart. This led him to unleash his investigative experience to find out why more hasn't been done... View Details

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Attention Please
In an age of constant information and infinite distractions, how can we pay more attention to our ... attention? This hour, TED speakers explore the battle for our awareness during the digital age. Guests include sociologist Zeynep Tufekci, podcast host Manoush Zomorodi, neuroscientist Amishi Jha, designer Tristan Harris, and computer scientist Jaron Lanier.
Now Playing: Science for the People

#475 Mother Nature is Trying to Kill You (Rebroadcast)
This week, we're learning how deadly and delightful our planet and its ecosystem can be. We're joined by biologist Dan Riskin, co-host of Discovery Canada's Daily Planet, to talk about his book "Mother Nature Is Trying to Kill You: a Lively Tour Through the Dark Side of the Natural World." And we'll talk to astronomer and author Phil Plait about Science Getaways, his company that offers educational vacation experiences for science lovers.